VIENNA--(BUSINESS WIRE)--Today, GE Healthcare’s Medical Diagnostics business (MDx) announced results of a pivotal study outlining the potential to use lower iodine concentration and reduced radiation exposure in an abdominal CT scanning procedure. The study showed that advanced CT reconstruction techniques such as ASiRTM or VeoTM, combined with the isosmolar contrast agent, VisipaqueTM (270 or 320mgI/ml) and low kVp, deliver equivalent or better contrast enhancement and improved diagnostic images when compared to iomeprol (400mgI/ml) injected at the same volume and rate (2ml/kg at 3,5ml/sec). By lowering both the radiation and iodine dose, the image quality was not compromised, thus ensuring confident diagnosis. The results of this study carried out by Dr. Jean-Louis Sablayrolles, Chief of the CT and MRI Department, Centre Cardiologique du Nord, St. Denis, France, were presented at the European Congress of Radiology (ECR) 2012 on Sunday 4th March, 2012.
